Ophthalmology
Volume 115, Issue 12 , Pages 2146-2152.e1, December 2008

Treatment of Ocular Mucous Membrane Pemphigoid with Immunosuppressive Drug Therapy

  • Jennifer E. Thorne, MD, PhD

      Affiliations

    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, Center for Clinical Trials, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence: Jennifer E. Thorne, MD, PhD, Wilmer Eye Institute, 550 North Broadway, Suite 700, Baltimore, MD 21205
    • ,
  • Fasika A. Woreta, MD, MPH

      Affiliations

    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Douglas A. Jabs, MD, MBA

      Affiliations

    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, Center for Clinical Trials, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Grant J. Anhalt, MD

      Affiliations

    • Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Received 5 March 2008; received in revised form 3 June 2008; accepted 1 August 2008. published online 20 October 2008.

Available online: October 18, 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Manuscript no. 2008-290.

 Dr Jabs is now at the Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York.

 Supported by the National Eye Institute, Baltimore, Maryland (grant nos.: EY-13707 [JET] and EY-00405 [DAJ]); and the Mildred Weiner Ocular MMP Research Fund, Baltimore, Maryland (JET). Dr Thorne is the recipient of a Research to Prevent Blindness Harrington Special Scholars Award.

 Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

PII: S0161-6420(08)00740-9

doi:10.1016/j.ophtha.2008.08.002

Ophthalmology
Volume 115, Issue 12 , Pages 2146-2152.e1, December 2008

Article Tools

* Image Usage & Resolution